Foghorn Therapeutics, Inc. (FHTX): Price and Financial Metrics
FHTX Price/Volume Stats
| Current price | $5.14 | 52-week high | $10.25 |
| Prev. close | $4.98 | 52-week low | $2.70 |
| Day low | $4.88 | Volume | 443,700 |
| Day high | $5.28 | Avg. volume | 142,217 |
| 50-day MA | $7.50 | Dividend yield | N/A |
| 200-day MA | $6.85 | Market Cap | 285.75M |
FHTX Stock Price Chart Interactive Chart >
Foghorn Therapeutics, Inc. (FHTX) Company Bio
Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology. Through its scalable Gene Traffic Control product platform, the firm is systematically interrogating and drugging the chromatin regulatory system. The company was founded by Cigall Kadoch, Gerald W. Crabtree and Douglas G. Cole in October 2015 and is headquartered in Cambridge, MA.
FHTX Price Returns
| 1-mo | -33.42% |
| 3-mo | -48.55% |
| 6-mo | -3.38% |
| 1-year | -23.51% |
| 3-year | -76.49% |
| 5-year | N/A |
| YTD | -20.31% |
| 2023 | 1.10% |
| 2022 | -72.10% |
| 2021 | 12.83% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...